BOSTON PHARMACEUTICALS
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jan 2031: the §8 declaration of use).
Record
- Serial number
- 98323673
- Registration number
- 7664968
- Mark type
- Design + words
- Filed
- 20 Dec 2023
- Published for opposition
- 02 Jul 2024
- Registered
- 21 Jan 2025
- Next maintenance filing
- §8 declaration of use, due by 21 Jan 2031 (grace period to 21 Jul 2031)
- Attorney of record
- Camille M. Miller
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- BP ASSET IX, INC., WILMINGTON, DE, US
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 03 Jun 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Aug 2024 — USE AMENDMENT FILED
- 29 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 27 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jul 2024 — PUBLISHED FOR OPPOSITION
- 12 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED